2024 Bipolar disorder Pharmaceuticals 
Mad in America
JULY 13, 2024
But Ghaemi wants to claim that lithium is special—that it does more than target symptom mechanisms, it modifies the disease process that underpins bipolar disorder. One member of the editorial board, Sameer Jauhar, posted approvingly about the article on X: ‘Nassir writes elegantly and imo he is correct’ ( Jauhar, 2024 ).
Mad in America
FEBRUARY 20, 2024
Stephenson and a team of researchers from various academic and pharmaceutical institutions, including the University of Virginia School of Medicine. Maelys Touya was an employee of Lundbeck LLC, and Lambros Chrones was an employee of Takeda Pharmaceuticals U.S.A., The study was authored by Judith J. Additionally, Anita H. Chrones, L.,
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Mad in America
JANUARY 4, 2025
In our 2015 book Psychiatry Under the Influence , Lisa Cosgrove and I wrote about the STAR*D scandal in depth, as it served as an example of the institutional corruption in psychiatry due to pharmaceutical interests and psychiatrys own guild interests. The 12 STAR*D authors listed a collective total of 151 ties to pharmaceutical companies.
Mad in America
JANUARY 9, 2025
But now they often say Since they have bipolar disorder, theyll never be able to manage their emotions or achieve any stability. Golec, J, Vernon, J European Pharmaceutical Price Regulation, Firm Profitability, and R & D Spending Working Paper 12676, National Bureau of Economic Research, Nov 2006.
Mad in America
DECEMBER 17, 2024
What is at stake here with this discussion is the billion-dollar business that the pharmaceutical companies make with their unproven myth that mental illness results from a chemical imbalance in the brain that can only be corrected by taking antipsychotic drugs. The statistics were updated in October 2024. Exile is the best option.
Expert insights. Personalized for you.
145 
Let's personalize your content